Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Hajra

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Postgraduate Medicine|October 13, 2017
Adenosine monophosphate- activated protein kinase- based classification of diabetes pharmacotherapyA Hajra, D Bandyopadhyay, S K Hajra
Indian Journal of Dermatology|January 1, 1981
Lepromin conversion after repeated lepromin administrationS K Hajra, S Chaudhury, S Ghosh, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|March 1, 1996
Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial)V Majumder, A Mukerjee, S K Hajra, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|February 28, 2001
Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesionV Majumder, B Saha, S K Hajra, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|March 1, 1997
Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in CalcuttaS Chaudhury, S K Hajra, A Mukerjee, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|September 5, 1998
Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granulomaS Chaudhuri, S K Hajra, A Mukherjee, et al.
Lancet (London, England)|May 29, 1982
Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosyS J Yawalkar, A C McDougall, J Languillon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Postgraduate Medicine|October 13, 2017
Adenosine monophosphate- activated protein kinase- based classification of diabetes pharmacotherapyA Hajra, D Bandyopadhyay, S K Hajra
Indian Journal of Dermatology|January 1, 1981
Lepromin conversion after repeated lepromin administrationS K Hajra, S Chaudhury, S Ghosh, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|March 1, 1996
Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial)V Majumder, A Mukerjee, S K Hajra, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|February 28, 2001
Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesionV Majumder, B Saha, S K Hajra, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|March 1, 1997
Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in CalcuttaS Chaudhury, S K Hajra, A Mukerjee, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|September 5, 1998
Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granulomaS Chaudhuri, S K Hajra, A Mukherjee, et al.
Lancet (London, England)|May 29, 1982
Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosyS J Yawalkar, A C McDougall, J Languillon, et al.
Pageof 1